Helicobacter pylori infection associated with gastritis and indigestion. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: First intervention group: Standard quadruple bismuth treatment containing pantoprazole: Pantoprazole tablets 40 mg twice a day , Tetracycline capsules 500 mg four times a day ,Metronid
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Helicobacter pylori positive Over 18 years old Informed consent to participate in the study
Exclusion criteria
Exclusion criteria: malignant neoplasms previous treatment for Helicobacter pylori eradication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication rate. Timepoint: 4 weeks after intervention. Method of measurement: Stool antigen test.;Percentage of response to treatment based on symptoms of the disease (pain, bloating, loss of appetite, heartburn). Timepoint: Before and after the intervention. Method of measurement: Patient history. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of treatment adherence. Timepoint: After the first and second weeks of intervention. Method of measurement: Researcher-made form for daily recording of treatment adherence.;Percentage of complications resulting from drug treatment. Timepoint: After the first and second weeks of intervention. Method of measurement: Researcher-made Adverse Drug Reaction Reporting Form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Raeisi
Shahre-kord University of Medical Sciences
Outcome results
None listed